Medical specialists from Austria tagged as investigators in clinical trials studying Lymphoma
Total 9 results
-
Daniel HeintelSeen in:
- Vienna, Klinik Ottakring
Trials:- NCT05023980 (Principal Investigator)
Conditions: -
Manuel OrlingerSeen in:
- Linz, Krankenhaus Barmherzige Schwestern Linz
- Oberösterreich, Linz, Ordensklinikum Linz
Trials:- NCT05254743 (Principal Investigator)
-
Markus Raderer, MDSeen in:
- Vienna, Dept of Internal Medicine
- Wien, University of Wien
Trials:- NCT00923663 (Principal Investigator)
- NCT04646395 (Principal Investigator)
Conditions: -
Michael GirschikofskySeen in:
- Linz, Ordensklinikum Linz GmbH Elisabethinen
- Oberösterreich, Linz, Ordensklinikum Linz GmbH Elisabethinen
Trials:- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Olga StiefelSeen in:
- Oberösterreich, Linz, Ordensklinikum Linz GmbH Elisabethinen
Trials:- NCT04662255 (Principal Investigator)
Conditions: -
Philipp StaberSeen in:
- Wien, Medizinische Universität Wien
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Richard GreilSeen in:
- Osterreich, Salzburg, Uniklinikum Salzburg
- Other, Salzburg, Salzburg Cancer Research Institute
- Salzburg, Landeskrankenhaus Salzburg
- Salzburg, Salzburg Cancer Research Institute (SCRI)
- Salzburg, UK Salzburg, LKH: Universitätsklinik für Innere Medizin III
- Salzburg, Uniklinikum Salzburg
- Salzburg, Uniklinikum Salzburg, Landeskrankenhaus, Universitatsklinik fur Innere Medizin III der PMU
- Salzburg, Uniklinikum Salzburg, Universitaetsklinik für Innere Medizin III der PMU
- Salzburg, Universitatsklinikum Salzburg
- Salzburg, Universitätsklinik für Innere Med. III, PMU Salzburg
- Salzburg, Universitätsklinik für Innere Medizin III, PMU Salzburg
Trials:- NCT04662255 (Principal Investigator)
- NCT04797780 (Principal Investigator)
- NCT04975308 (Principal Investigator)
- NCT04420884 (Principal Investigator)
- NCT05514054 (Principal Investigator)
- NCT05556616 (Principal Investigator)
- NCT05253651 (Principal Investigator)
- NCT04438889 (Principal Investigator)
- NCT04654364 (Principal Investigator)
- NCT06250465 (Principal Investigator)
- NCT06294652 (Principal Investigator)
Conditions: -
Thomas NösslingerSeen in:
- Vienna, Hanusch Krankenhaus
Trials:- NCT05254743 (Principal Investigator)
Clinical Trials on Lymphoma
-
Marcela V. Maus, M.D.,Ph.D.RecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Non-hodgkin Lymphoma | High-grade B-cell Lymphoma | Grade 3b Follicular Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
IGM Biosciences, Inc.ADC Therapeutics S.A.Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | DLBCLUnited States, Korea, Republic of, Spain, France, Australia, Czechia, Italy
-
Zhejiang UniversityShanghai First Song Therapeutics Co., LtdNot yet recruitingHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Gray Zone Lymphoma | NK/T Cell Lymphoma | Peripheral T Cell Lymphoma, Unspecified | Mediastinal B-Cell Diffuse Large Cell LymphomaChina
-
SymBio PharmaceuticalsCompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma | Lymphoma, Large Cell | Diffuse, Mantle Cell Lymphoma, Lymphoma | Large B-Cell, DiffuseJapan, Korea, Republic of
-
Massachusetts General HospitalTG TherapeuticsTerminatedLymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma Grade IIIa | Marginal Zone B Cell Lymphoma | Follicular Lymphoma Grade 2United States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin Lymphoma | Adult Diffuse Large B-Cell Lymphoma | T-Cell Non-Hodgkin LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell LymphomaUnited States